HISAMITSU PHARMACEUTICAL CO.,INC.JP:4530
Market cap
¥391,588m
P/E ratio
29.1
| Feb 28, 2010 | Feb 28, 2011 | Feb 29, 2012 | Feb 28, 2013 | Feb 28, 2014 | Feb 28, 2015 | Feb 29, 2016 | Feb 28, 2017 | Feb 28, 2018 | Feb 28, 2019 | Feb 29, 2020 | Feb 28, 2021 | Feb 28, 2022 | Feb 28, 2023 | |
| Net sales | 129,834 | 137,184 | 137,794 | 142,772 | 150,635 | 156,791 | 161,895 | 145,962 | 148,466 | 143,408 | 140,992 | 114,510 | 120,193 | 128,330 |
| Ordinary profit (loss) | 31,231 | 33,236 | 33,494 | 33,051 | 28,910 | 28,489 | 28,008 | 28,179 | 28,245 | 24,647 | 25,628 | 11,829 | 12,638 | 16,051 |
| Profit (loss) attributable to owners of parent | ||||||||||||||
| Comprehensive income | ||||||||||||||
| Basic earnings (loss) per share | ||||||||||||||
| Diluted earnings per share | ||||||||||||||
| Net cash provided by (used in) operating activities | ||||||||||||||
| Net cash provided by (used in) investing activities | ||||||||||||||
| Net cash provided by (used in) financing activities |